The Influence of Appetite-Related Central and Gut Hormones in Modulating Binge Eating Behaviour in Obese and Overweight Healthy Subjects
Phase of Trial: Phase IV
Latest Information Update: 08 May 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Binge-eating disorder
- Focus Therapeutic Use
- 08 Mar 2015 Results (obese patients n=42) presented at The 97th Annual Meeting of the Endocrine Society.
- 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
- 08 Jan 2013 New trial record